1
Wet Macular Degeneration Study to Compare Ranibizumab or Bevacizumab to Aflibercept
Condition(s):Exudative Macular DegenerationLast Updated:July 26, 2018Completed
Wet Macular Degeneration: 404 Clinical Trials, Page 1 of 41
Hide Studies Not Open or Pending
2
Analysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema and Exudative Macular Degeneration
Condition(s):Exudative Macular Degeneration; Diabetic Macular EdemaLast Updated:December 17, 2014Completed
3
Optimizing the Treatment Strategy for Age-related Macular Degeneration
Condition(s):Wet Macular DegenerationLast Updated:June 9, 2020Recruiting
4
The IAI-OCTA Study; a Study of OCT-Angiography Analysis Efficacy
Condition(s):Wet Macular DegenerationLast Updated:February 10, 2020Active, not recruiting
5
Non-Persistence/Non-Adherence (NP/NA) in Wet Age-related Macular Degeneration (wAMD) Patients in Germany
Condition(s):Wet Macular DegenerationLast Updated:September 14, 2015Completed
6
A Study to Evaluate the Efficacy and Safety of KSI-301, an Anti-VEGF Antibody Biopolymer Conjugate, Versus Aflibercept in Patients With Neovascular (Wet) Age-Related Macular Degeneration.
Condition(s):Wet Macular DegenerationLast Updated:December 23, 2019Recruiting
7
Ziv-aflibercept Efficacy in Better Regulating AMD
Condition(s):Wet Macular Degeneration; Wet Age-related Macular DegenerationLast Updated:October 3, 2019Active, not recruiting
8
Pilot Study of Ranibizumab With and Without Ketorolac Eyedrops for Exudative Age-related Macular Degeneration
Condition(s):Wet Macular DegenerationLast Updated:February 12, 2014Completed
9
Efficacy of Biweekly Ranibizumab (0.5 mg) for Exudative Macular Degeneration Retinal Edema Refractory to Anti-VEGF
Condition(s):Exudative Age Related Macular DegenerationLast Updated:April 8, 2019Active, not recruiting
10
Open-Label Study of Intravitreal ICON-1 in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD)
Condition(s):Choroidal Neovascularization; Wet Macular DegenerationLast Updated:November 8, 2018Active, not recruiting